Return to Trial Database

HN02-40

A Single Arm Phase II Trial of Docetaxel and Capecitabine for the First Line Treatment of Recurrent/ Metastatic Squamous Cell Carcinoma of the Head and Neck

Status

Study Completed

Cancer Type(s)

Study Contact

Trial Locations

All sites in which the trial HN02-40 being conducted in.

No data was found